Development Level

Tbio 3 | 10,625

IMPC Term

abnormal lens morphology 1 | 73
cataract 1 | 26

Disease

non-small cell lung cancer 3 | 2,798
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
Breast cancer 2 | 3,094
Mesothelioma 2 | 40
Tularemia 2 | 22
chronic lymphosyte leukemia 2 | 232
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis 2 | 1,665
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
osteosarcoma 2 | 7,933
pituitary cancer 2 | 1,972
subependymal giant cell astrocytoma 2 | 2,287
ulcerative colitis 2 | 2,087
Adenocarcinoma 1 | 115
Adenocarcinoma Of Esophagus 1 | 14
Adenocarcinoma in situ 1 | 15
Adenoma 1 | 165
Adrenal Gland Neoplasms 1 | 11
Allergic hypersensitivity disease 1 | 123
Barrett's esophagus 1 | 183
Bladder Neoplasm 1 | 109
Brain Neoplasms 1 | 23
Cancer 1 | 2,346
Carcinoma, Pancreatic Ductal 1 | 19
Cervicitis 1 | 6
Cervix uteri carcinoma in situ 1 | 14
Colorectal Neoplasms 1 | 217
Diffuse large B-cell lymphoma 1 | 41
Dracunculiasis 1 | 6
Dysplastic nevus syndrome 1 | 7
Esophageal Neoplasms 1 | 67
Esophageal carcinoma 1 | 5
Genitourinary Neoplasms 1 | 3
Glaucoma 1 | 134
Glioma 1 | 65
Gout 1 | 93
Head and neck squamous cell carcinoma 1 | 12
IGA Glomerulonephritis 1 | 454
Kidney failure 1 | 39
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3 1 | 20
LI-FRAUMENI SYNDROME 1 1 | 2
Li-Fraumeni Syndrome 1 | 13
Liver carcinoma 1 | 217
Liver neoplasms 1 | 109
Loiasis 1 | 6
Lung Neoplasms 1 | 171
Lupus erythematosus 1 | 80
Lymphoid leukemia 1 | 69
Lymphoma 1 | 56
Lymphoma, T-Cell, Cutaneous 1 | 21
MELANOMA, CUTANEOUS MALIGNANT, 1 1 | 4
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Micronuclei, Chromosome-Defective 1 | 19
Neoplasm Invasiveness 1 | 127
Neoplastic Syndromes, Hereditary 1 | 48
Neuroblastoma 1 | 78
Pancreatic Neoplasm 1 | 79
Pancreatic carcinoma, familial 1 | 8
Papilloma 1 | 27
Peripheral Neuropathy 1 | 303
Primary cutaneous amyloidosis 1 | 26
Prostate cancer 1 | 172
Rheumatic fever 1 | 16
Sezary Syndrome 1 | 26
Skin cancer 1 | 37
Spotted fever 1 | 7
Squamous cell carcinoma of esophagus 1 | 82
Squamous cell carcinoma of the head and neck 1 | 24
Stomach Neoplasms 1 | 282
Thymoma 1 | 16
Tinea corporis 1 | 25
Upper respiratory tract disease 1 | 7
Vascular disease 1 | 281
Vulvar Lichen Sclerosus 1 | 2
Wolf-Hirschhorn syndrome 1 | 32
active Crohn's disease 1 | 918
active ulcerative colitis 1 | 477
adrenocortical carcinoma 1 | 1,427
adult high grade glioma 1 | 2,148
astrocytoma 1 | 1,493
atypical teratoid/rhabdoid tumor 1 | 1,095
breast carcinoma 1 | 1,614
cat-scratch disease 1 | 9
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
mucosa-associated lymphoid tissue lymphoma 1 | 480
nasopharyngeal carcinoma 1 | 1,056
non-small cell lung carcinoma 1 | 413
pancreatic cancer 1 | 2,300
pediatric high grade glioma 1 | 2,712
pilocytic astrocytoma 1 | 3,086
progressive supranuclear palsy 1 | 674
sarcoidosis 1 | 358
tuberculosis 1 | 1,557

Tissue

Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Digestive Tract 3 | 18,473
Endocrine System 3 | 18,512
Female tissues 3 | 18,647
Liver and Pancreas 3 | 18,136
Male tissues 3 | 17,969
Nervous System 3 | 18,561
Respiratory system 3 | 17,484
Skin and soft tissues 3 | 18,115
Urinary Tract 3 | 18,444

Target Family

Non-IDG 2 | 11,971
Enzyme 1 | 4,146

Grant Application

5R01AI060559-02 3 | 3
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Protein phosphatase 1 regulatory subunit 14A PPP1R14A Tbio Enzyme -2.51350 314.7 189
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Tumor suppressor ARF CDKN2A Tbio Non-IDG -3.90375 8561.3 896